Rapid risk assessment: Zika virus disease epidemic. 10th update, 4 April 2017
This is an updated assessment of the risks associated with the Zika virus epidemic in affected countries, EU Overseas Countries and Territories, and Outermost Regions and in EU Member States within continental Europe.
Communicable disease threats report, 24-30 June 2018, week 26
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 June 2018, and includes updates on Vibrio growth in the Baltic sea, polio, Ebola virus disease, West Nile Virus, and mass gathering monitoring – FIFA World Cup 2018.
The extinction of dengue through natural vulnerability of its vectorsArchived
Aedes aegypti is a highly specialized mosquito species feeding predominantly on humans and breeding in artificial water holding containers in urban areas, and currently restricted to subtropical and tropical areas. Williams et al. focus on the reasons why Ae. aegypti once occurred in locations where the mosquito does not occur anymore in Australia, the more temperate drier parts of the country.
Rapid risk assessment: Oseltamivir-resistant influenza A(H1N1)2009 cluster in Australia
Australia has reported a cluster of oseltamivir-resistant influenza A(H1N1)2009 cases in the state of New South Wales. The cases had no known link to oseltamivir exposure and individuals were not immunosuppressed, but they were closely linked geographically. Samples from the cluster do not currently exhibit any resistance to zanamivir.
Oseltamivir-resistant influenza A(H1N1)pdm09 patterns across the globe: findings in Australia (season 2011) and United States (season 2010-11)Archived
In this letter the authors describe being able to identified a sustained community transmission of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Australia
ECDC: first detected cases of extensively drug-resistant gonorrhoea threaten future treatment
Within a matter of weeks, three cases of gonorrhoea that are resistant to the recommended first line antibiotic treatment have been detected in Europe and Australia. These are the first global reports of Neisseria gonorrhoeae with high-level resistance to azithromycin and ceftriaxone resistance that also show resistance to several other vital antibiotics. At a time with limited alternatives to the current dual therapy, lack of a vaccine and insufficient surveillance capacity in some regions, these cases highlight the growing threat of drug-resistance – which could lead to untreatable gonorrhoea.